Ad Scientiam Launches Programs to Develop Digital Biomarkers for Chronic Neurological Diseases
February 28, 2023 08:00 ET
|
Ad Scientiam
PARIS, FRANCE, Feb. 28, 2023 (GLOBE NEWSWIRE) -- On Rare Disease Day, Ad Scientiam, a leader in digital biomarkers, announced the launch of two ambitious programs to develop and validate novel...